Medical Management of Sleep Disturbance During Opioid Tapering

NCT03789214 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence
Opioid Withdrawal
Sleep Disturbance

Interventions

DRUG: Placebo oral capsule
DRUG: Low Dose Suvorexant
DRUG: High Dose Suvorexant

Sponsor

Johns Hopkins University

Collaborators

[object Object]